CSL's billion bucks into R&D

Posted 19 October 2021 PM 

CSL invested more than $1 billion in research and development in the past fiscal year, the first time in its 105 year history, and announced today (Tuesday) it will open the Centre for Biologic Therapies with the Walter and Eliza Hall Institute (WEHI).

The collaboration with the WEHI will provide access to expert biologic discovery and optimisation capabilities, to generate clinic-ready therapeutic antibodies against novel targets in human disease.

To see the whole article, please login